Kevin J. Appelbaum - Dec 2, 2021 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Signature
/s/ Mark Heinen, Attorney-in-Fact for Kevin J. Appelbaum
Stock symbol
BTTX
Transactions as of
Dec 2, 2021
Transactions value $
$6,633
Form type
4
Date filed
12/6/2021, 04:34 PM
Previous filing
Nov 1, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $3.42K +500 $6.84* 500 Dec 2, 2021 Direct
transaction BTTX Common Stock Purchase $3.21K +500 +100% $6.43* 1K Dec 3, 2021 Direct F1
holding BTTX Common Stock 2.41M Dec 2, 2021 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.440 to $6.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of the Issuer.